Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion type Assertion NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_head.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion description "[These observations indicate a promising role for IL-13R?2 as a target for antibody treatment in malignant mesothelioma, and, in combination with epigenetic regulation by a DNA methylation inhibitor, suggest the potential for a novel strategy to enhance therapeutic potency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_provenance.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion evidence source_evidence_literature NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_provenance.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion SIO_000772 21357681 NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_provenance.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion wasDerivedFrom befree-20150227 NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_provenance.
- NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_assertion wasGeneratedBy ECO_0000203 NP506854.RAiYEONg2leyfDIbHzyYw7iZtoWWNe7wTJsv933uICeu8130_provenance.